Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSXV: $RLV.V) (OTCQB:
$RLLVF)
(OTC: $AGTK) (OTCQB: $NUGS) (OTCQB: $HLIX)
(CSE: $SLNG.C) (OTC: $EDXC)
Delta, Kelowna, BC, March 3rd, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public announcements.
Relevium
Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) announced that
the Company’s subsidiary, BGX E-Health LLC, has shipped a total of CAD $130,000
worth of generic formulations to its customer, Innova Health Care based in
Saudi Arabia.
This
represents the first shipment of the initial CAD $1,000,000 purchase order the
Company received, as mentioned in a press release dated October 30th
2019.
CEO
of Relevium Mr. Useche stated “This first shipment to our international
customer presents a new milestone for the Company as it embarks on expanding
with global partners around the world for generic formulations and
nutraceuticals.” Mr. Useche stated further “Our manufacturing partnerships have
enabled us to expand our footprint into international markets such as Saudi
Arabia and diversify our global sales channels which stem mainly through online
sales”.
The
Company anticipates that the shipment for the remainder of the purchase order,
valued at approximately CAD $870,000 will be shipped towards the end of March
2020.
Agritek Holdings,
Inc. (OTC:
AGTK), a fully integrated, active real estate investor and
white label provide for popular hemp brands, today
announced that the Company will utilize its partnerships with
licensed facilities in Florida, Colorado and California to focus on the
cultivation and extraction of highly enriched CBG hemp, based on a new medical
study that CBG material may have antibiotic potential to fight viral disease in
humans.
Recently,
McMaster University researchers have identified an antibacterial compound made
by cannabis plants that may serve as a lead for new drug development. An
interdisciplinary team of McMaster researchers found that the chemical
compound, or cannabinoid, called cannabigerol (CBG) is not only antibacterial
but also effective in mice against a resilient family of bacteria known as
methicillin-resistant Staphylococcus aureus (MRSA). CBG achieved this by
targeting the cell membrane of the bacteria. These findings in the laboratory
were supported when mice with an MRSA infection were given CBG. The findings were
published in the journal American Chemical Society Infectious Diseases.
Agritek
Holdings presently has extracted multiple liters of hemp crude oil containing
both CBD and CBG hemp material from last year’s farming operations and hemp
harvest in Colorado to be used within multiple nutraceutical product lines.
“This
new study clearly seems to show evidence and potential for use of CBG
cannabinoids as antibiotics which have proven effective in mice against a
resilient family of bacteria known as methicillin-resistant Staphylococcus
aureus (MRSA). With rapid spread and growing worldwide concern of the
coronavirus or COVID-19, perhaps further research on the effectiveness of
cannabis’ deeper spectrum can be driven by new and exciting proofs that
cannabis can one day help kill superbugs. This realistic approach might be a
first important step in our need to improve society’s resistance to disease
through a generic means,” stated B. Michael Friedman, CEO of Agritek holdings.
Despite
the shock and awe of the traditional pharma community, it is no surprise to see
powerful antibacterial effects from CBG in combination with other medications.
The effect of the endocannabinoid system helps
increase the potency of other antibacterial agents through its major functions.
Beyond germs, cannabigerol can slow the spread of viruses throughout the body.
CBG can stop the replication of viral infections by inhibiting calcium through
several pathways, such as agonizing PPAR-y, a regulator of genetics,
tumorigenesis, and many cellular processes. This leads to a widespread
anti-inflammatory response that can help orchestrate white blood cells as they
attack diseases, like pneumonia. In terms of relieving symptoms, nitric oxide
is pneumonia’s weapon of inflammation which cannabis, CBD more than CBG, is an
expert at disarming.
Research
on this topic is still at an early stage to answer if cannabinoid formulations
can truly deal with epidemics as severe as the current form of coronavirus now
COVID-19 and originally the Wuhan Virus spreading in Southeast Asia, Europe and
now entering the United States and Canada. We do not currently understand the
pathogenesis of the disease, in order to develop vaccines or to employ
medicinal intervention. Yet, that is the exact point of generic instant
treatment, something that cannot be relied upon but can still be delivered with
benefits that outweigh the risks. According to current research, CBG is
non-intoxicating, mostly non-toxic, and non-sedating so it carries little known
risk. The development of cannabinoid formulations might be able to unlock a
range of interventions for many outbreaks, bacteria or viral.
Cannabis Strategic
Ventures
(OTCQB:NUGS), an
emerging leader in the U.S. and California cannabis marketplaces, announced robust
growth and significant financial improvements for the most recently completed
financial period ending Dec. 31, 2019.
Revenue for the quarter ending Dec. 31 reached $1.35 million,
representing sequential quarterly growth of approximately 91 percent, compared
to the previous quarter. Gross margins
grew meaningfully while operating efficiencies improved significantly.
“We’re
excited to see consistent revenue growth,” commented Simon Yu, CEO of the
Company. “In this highly regulated
environment, it takes time to scale production.
With a considerable portion of the permitting and construction behind
us, we are poised for continued growth in the California cannabis marketplace.”
In
addition to top-line growth, the Company’s total assets as of the end of the
December quarter 2019 was just over $18.7 million from only $2.8 million for
the year-ago period. Total current
assets now equal approximately 113 percent of current liabilities. Cash and accounts receivables more than
doubled as of the end of the nine-month period.
Gross
margins for the December 2019 quarter rose to just over 33 percent from 25
percent for the nine month period ending Dec. 31, 2019, and from no gross
margin production for the year-ago quarter.
The net loss for the December quarter was cut to approximately $1.2
million from over $4.5 million during the September 2019 quarter. Expense ratios improved markedly for the
periods ending Dec. 31, 2019.
Mr.
Yu continued, “Both the business operations and our financials continue to
trend positively. We have been able to
substantially grow revenues and improve our gross margins while reducing our
operational costs. We feel we are now
starting to hit our business stride in the California regulated marketplace,
and we look forward to a fruitful 2020.”
This
robust growth follows what was already strong growth during the September
quarter of 2019. For the nine month
period ending December 31, Cannabis Strategic was able to increase revenues by
more than $2 million. The Company
expects strong revenue growth to continue for the foreseeable future.
Helix Technologies,
Inc.
(OTCQB:HLIX), the
leading provider of critical infrastructure services to the legal cannabis
industry, announced
today that it has extended two Government Traceability
contracts in New York and North Dakota, and will deploy 2 advanced patient
registries and upgraded traceability services in Arkansas and New Mexico.
New
York and North Dakota have chosen to extend the contract of Biotrack’ss Government
Traceability software. Biotrack’s
solution maintains a >99.99% uptime record, and best in class digital
security features, such as being the only traceability system to deploy in the
AWS FEDRAMP GOVCLOUD and to successfully complete a SOC 2 Type II Audit.
In
addition, Arkansas and New Mexico also upgraded to the Biotrack advanced
patient registry solution, including online application and approval, and
mobile patient ID cards.
These
innovative solutions have reduced costs, approval time, and hassle for
patients. Further, Biotrack is deploying upgrades to the New Mexico system that
allows for on-site consumption, and reciprocity between states with medical
cannabis programs, improving patient access.
“Delivering
cutting edge systems requires fully-secure development capabilities and
functionality coupled with the deployment expertise to meet the demands of the
industry. In the end, this is about
patient access to medication,” said Helix Technologies CEO and Executive
Chairman Zachary L. Venegas. “We consider it a tremendous responsibility to
ensure patients have access to medication that is safe and tested, while also
protecting the integrity of patient data privacy.”
SLANG Worldwide
Inc.
(CSE:
SLNG), a leading global cannabis consumer packaged goods
company with a robust portfolio of popular brands,
today announced that it has entered into an acquisition
agreement dated March 2, 2020 to acquire Cultivate Brands Corp.
Cultivate
is a privately-owned company with a portfolio of brands and other intellectual
property which are complementary to SLANG's portfolio. Its assets include
extraction equipment and other machinery which SLANG intends to use within its
network, cash of approximately CAD $4.5 million, and a strategic investment in
a company within the supply chain. Cultivate is not currently consuming any
cash in its operations.
The
Acquisition is expected to further strengthen SLANG's position in Oregon, which
the Company has identified as a core market for growth in 2020, due to its
status as one of the most mature recreational markets in the United States.
SLANG's O.penVAPE Craft RESERVE and Bakked Dabaratus products are strong
performers in the state, and the Company recently announced a strategic partnership
in Oregon with Cookies, a leading third-party brand that the Company expects to
launch in Q2 2020. The Oregon market had
retail sales of $810M USD during 2019 and grew 27% year over year as of
December 2019 (per BDS Analytics).
The
Acquisition is structured as an all-stock transaction in which SLANG will issue
a non-material amount of common shares in exchange for all the issued and
outstanding shares of Cultivate. The
majority of the SLANG Shares issued pursuant to the Acquisition will be subject
to a lock-up period with rolling expiration dates.
"We
are pleased to execute a deal that contributes brands, IP, equipment, and
capital to the already robust SLANG portfolio and balance sheet," said
SLANG CEO Peter Miller. "The acquisition of Cultivate will provide a
unique opportunity to generate value in several ways including new production
assets, supply chain efficiencies and potential new products. This acquisition is consistent with our
disciplined growth strategy and our focus on capital efficiency."
"We
are pleased to align with a leading cannabis CPG company like SLANG, with its
proven capability to develop and grow brands," said Mihalis Belantis,
Founder of Cultivate. "This transaction offers significant potential
upside to our investors, as well as an opportunity to leverage and
commercialize the foundational work we completed during the start-up phase of
our business."
The
Acquisition will be completed by way of three-cornered amalgamation and is
anticipated to close in April 2020. Closing of the Acquisition is subject to
the satisfaction or waiver of customary closing conditions, including the
receipt of the approval of the shareholders of Cultivate and applicable
regulatory approvals.
CBD
Unlimited, Inc. (OTC:
EDXC), formerly known as Endexx Corporation, a provider of
innovative phytonutrient-based food and nutritional products, announced the
Company's interview with Stock News Report at the Nasdaq MarketSite is now
publicly available for viewing.
On February 14,
2020, CBD Unlimited's Chief Executive Officer and Chairman, Todd Davis, appeared
live at the Nasdaq MarketSite with Stock News Now where Davis unveiled the
Company's successful product launch, growth within mass retail/pharmacy
outlets, international growth, the company's scientific background, testing
product efficacy and dosing, acquisition targets, and record revenues. CBD
Unlimited believes the Company is well positioned to capitalize on its large
retail relationships while boosting sales in 2020.
"It was a
pleasure to join Jane King with Stock News Now. Our diligent work in the hemp
marketplace is paying off with strong growth, revenues, and near-term
completion of acquisitions that will truly position the company as an industry
powerhouse," commented Chief Executive Officer and Chairman, Todd Davis.
"All of CBD
Unlimited's products are designed with our scientifically-based therapeutics
and formulated with natural adaptogen herbs such as ashwagandha, turmeric,
ginger, and other viable plant properties that pair well with CBD,"
continued Davis. "The synergies we have developed between mass retailers,
mass pharmacy, and our dedicated partners will continue to help fuel the
Company's growth and we look forward to what the rest of 2020 has to hold for
the hemp marketplace."
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment